Problem statement: Answer the multiple choice question.
Question: Which drug exhibits a 10.605% human ether-à-go-go related gene (hERG) inhibition at 10uM?
Constraint: You must select none, one or more options from a, b, c, d, or e without using any additional words.
Options:
[a] COc1ccccc1-n1nnnc1SCc1cc2c(cc1Br)OCO2
[b] CCOc1ccc(N2CC(C(=O)NCc3cccc(C)c3)CC2=O)cc1
[c] COCCN1CCN(C(=O)c2cc(COc3cncc(Cl)c3)on2)CC1
[d] CCc1ccc(C2C3=C(CCCC3=O)OC3=C2C(=O)CCC3)cc1
[e] Cc1nn(-c2ccccc2)c(Cl)c1/C=N/NC(=O)CNc1n[nH]c(=O)[nH]c1=O
Answer: c. COCCN1CCN(C(=O)c2cc(COc3cncc(Cl)c3)on2)CC1
{#Task|Problem statement!}: Answer the {#multiple choice|multiple-choice|MCQ!} question.
{#Question|Query!}: Which {#compound|drug!} {#has|exhibits!} a {herg_central_at_10uM#}{herg_central_at_10uM__units} {herg_central_at_10uM__names__noun}?
Constraint: You must select none, one or more options from {%multiple_choice_enum%2-5%aA1} without using any {#other|additional!} words.
Options:
{SMILES%herg_central_at_10uM%}
Answer: {%multiple_choice_result}. {SMILES#}
COCCN1CCN(C(=O)c2cc(COc3cncc(Cl)c3)on2)CC1
COCCN1CCN(C(=O)c2cc(COc3cncc(Cl)c3)on2)CC1
[5-[(5-chloropyridin-3-yl)oxymethyl]-1,2-oxazol-3-yl]-[4-(2-methoxyethyl)piperazin-1-yl]methanone